ArticleCancer research2010
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.
Yoon-La Choi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
89 papers cite itlatest 60 shown
this paperpooled ittrialcites it